BIOMAT Database Logo BIOMAT Database Logo

Schizophrenia, sensory gating, and nicotinic receptors. 1998

L E Adler, and A Olincy, and M Waldo, and J G Harris, and J Griffith, and K Stevens, and K Flach, and H Nagamoto, and P Bickford, and S Leonard, and R Freedman
University of Colorado Health Sciences Center and the Denver Veterans Medical Center 80262, USA.

A series of human and animal investigations has suggested that altered expression and function of the alpha7-nicotinic cholinergic receptor may be responsible for the auditory sensory gating deficit characterized in schizophrenia patients and their relatives as diminished suppression of an auditory-evoked response (P50) to repeated stimuli. This finding, in conjunction with evidence for familial transmission of this sensory gating deficit, suggests a pathogenic role of the gene for the alpha7-nicotinic receptor in schizophrenia. This article considers the possible effects of this dysfunction in a broader context. Not only is this dysfunction consistent with difficulties in sensory gating, but it might also predispose patients to problems with learning efficiency and accuracy. Such learning problems could underlie schizophrenia patients' delusional thinking, hallucinations, and social dysfunction. In addition, heavy smoking in many schizophrenia patients is consistent with the high concentration of nicotine necessary to activate the receptor and with the receptor's extremely rapid desensitization. Finally, the receptor's possible role in cell growth and differentiation should be considered in connection with developmental deficits and other cellular abnormalities in schizophrenia.

UI MeSH Term Description Entries
D007858 Learning Relatively permanent change in behavior that is the result of past experience or practice. The concept includes the acquisition of knowledge. Phenomenography
D008959 Models, Neurological Theoretical representations that simulate the behavior or activity of the neurological system, processes or phenomena; includes the use of mathematical equations, computers, and other electronic equipment. Neurologic Models,Model, Neurological,Neurologic Model,Neurological Model,Neurological Models,Model, Neurologic,Models, Neurologic
D009415 Nerve Net A meshlike structure composed of interconnecting nerve cells that are separated at the synaptic junction or joined to one another by cytoplasmic processes. In invertebrates, for example, the nerve net allows nerve impulses to spread over a wide area of the net because synapses can pass information in any direction. Neural Networks (Anatomic),Nerve Nets,Net, Nerve,Nets, Nerve,Network, Neural (Anatomic),Networks, Neural (Anatomic),Neural Network (Anatomic)
D009433 Neural Inhibition The function of opposing or restraining the excitation of neurons or their target excitable cells. Inhibition, Neural
D009434 Neural Pathways Neural tracts connecting one part of the nervous system with another. Neural Interconnections,Interconnection, Neural,Interconnections, Neural,Neural Interconnection,Neural Pathway,Pathway, Neural,Pathways, Neural
D011978 Receptors, Nicotinic One of the two major classes of cholinergic receptors. Nicotinic receptors were originally distinguished by their preference for NICOTINE over MUSCARINE. They are generally divided into muscle-type and neuronal-type (previously ganglionic) based on pharmacology, and subunit composition of the receptors. Nicotinic Acetylcholine Receptors,Nicotinic Receptors,Nicotinic Acetylcholine Receptor,Nicotinic Receptor,Acetylcholine Receptor, Nicotinic,Acetylcholine Receptors, Nicotinic,Receptor, Nicotinic,Receptor, Nicotinic Acetylcholine,Receptors, Nicotinic Acetylcholine
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005072 Evoked Potentials, Auditory The electric response evoked in the CEREBRAL CORTEX by ACOUSTIC STIMULATION or stimulation of the AUDITORY PATHWAYS. Auditory Evoked Potentials,Auditory Evoked Response,Auditory Evoked Potential,Auditory Evoked Responses,Evoked Potential, Auditory,Evoked Response, Auditory,Evoked Responses, Auditory,Potentials, Auditory Evoked
D006624 Hippocampus A curved elevation of GRAY MATTER extending the entire length of the floor of the TEMPORAL HORN of the LATERAL VENTRICLE (see also TEMPORAL LOBE). The hippocampus proper, subiculum, and DENTATE GYRUS constitute the hippocampal formation. Sometimes authors include the ENTORHINAL CORTEX in the hippocampal formation. Ammon Horn,Cornu Ammonis,Hippocampal Formation,Subiculum,Ammon's Horn,Hippocampus Proper,Ammons Horn,Formation, Hippocampal,Formations, Hippocampal,Hippocampal Formations,Hippocampus Propers,Horn, Ammon,Horn, Ammon's,Proper, Hippocampus,Propers, Hippocampus,Subiculums

Related Publications

L E Adler, and A Olincy, and M Waldo, and J G Harris, and J Griffith, and K Stevens, and K Flach, and H Nagamoto, and P Bickford, and S Leonard, and R Freedman
Nicotinic receptor desensitization and sensory gating deficits in schizophrenia.
July 1998, Biological psychiatry,
L E Adler, and A Olincy, and M Waldo, and J G Harris, and J Griffith, and K Stevens, and K Flach, and H Nagamoto, and P Bickford, and S Leonard, and R Freedman
Sensory gating, cannabinoids and schizophrenia.
April 2013, Neuropharmacology,
L E Adler, and A Olincy, and M Waldo, and J G Harris, and J Griffith, and K Stevens, and K Flach, and H Nagamoto, and P Bickford, and S Leonard, and R Freedman
Schizophrenia and nicotinic receptors.
January 1994, Harvard review of psychiatry,
L E Adler, and A Olincy, and M Waldo, and J G Harris, and J Griffith, and K Stevens, and K Flach, and H Nagamoto, and P Bickford, and S Leonard, and R Freedman
Nicotinic receptors and schizophrenia.
July 2004, Current medical research and opinion,
L E Adler, and A Olincy, and M Waldo, and J G Harris, and J Griffith, and K Stevens, and K Flach, and H Nagamoto, and P Bickford, and S Leonard, and R Freedman
Current progress in schizophrenia research: sensory gating deficit in schizophrenia: is the nicotinic alpha-7 receptor implicated?
August 2002, The Journal of nervous and mental disease,
L E Adler, and A Olincy, and M Waldo, and J G Harris, and J Griffith, and K Stevens, and K Flach, and H Nagamoto, and P Bickford, and S Leonard, and R Freedman
Targeting of α7 Nicotinic Acetylcholine Receptors in the Treatment of Schizophrenia and the Use of Auditory Sensory Gating as a Translational Biomarker.
January 2015, Current pharmaceutical design,
L E Adler, and A Olincy, and M Waldo, and J G Harris, and J Griffith, and K Stevens, and K Flach, and H Nagamoto, and P Bickford, and S Leonard, and R Freedman
Activation of cannabinoid-1 receptors disrupts sensory gating and neuronal oscillation: relevance to schizophrenia.
June 2008, Biological psychiatry,
L E Adler, and A Olincy, and M Waldo, and J G Harris, and J Griffith, and K Stevens, and K Flach, and H Nagamoto, and P Bickford, and S Leonard, and R Freedman
Nicotinic receptors in sensory ganglia.
August 1980, Brain research,
L E Adler, and A Olincy, and M Waldo, and J G Harris, and J Griffith, and K Stevens, and K Flach, and H Nagamoto, and P Bickford, and S Leonard, and R Freedman
Allosteric alpha-7 nicotinic receptor modulation and P50 sensory gating in schizophrenia: a proof-of-mechanism study.
January 2013, Neuropharmacology,
L E Adler, and A Olincy, and M Waldo, and J G Harris, and J Griffith, and K Stevens, and K Flach, and H Nagamoto, and P Bickford, and S Leonard, and R Freedman
Sensory gating deficits in schizophrenia: new results.
April 1992, The American journal of psychiatry,
Copied contents to your clipboard!